Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2025	Mar. 31, 2025
ASSETS
Cash and cash equivalents	$ 9,128	$ 10,769
Restricted cash and cash equivalents	2,477	2,490
Investments in marketable securities	4,781	4,581
Finance receivables, net of allowance for credit losses of $1,547 and $1,644, respectively	100,301	101,749
Investments in operating leases, net	30,091	30,090
Other assets	5,437	5,615
Total assets	152,215	155,294
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	123,158	127,745
Deferred income taxes	2,871	2,973
Other liabilities	8,128	7,333
Total liabilities	134,157	138,051
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at June 30, 2025 and March 31, 2025	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(53)	(56)
Retained earnings	17,194	16,382
Total shareholder's equity	18,058	17,243
Total liabilities and shareholder's equity	$ 152,215	$ 155,294